Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans
将 Brainshuttle™ 淀粉样β抗体融合蛋白 trontinemab 递送至非人类灵长类动物脑部,并预计在人类中有效剂量方案
期刊:MAbs
影响因子:5.6
doi:10.1080/19420862.2023.2261509
Hans Peter Grimm, Vanessa Schumacher, Martin Schäfer, Sabine Imhof-Jung, Per-Ola Freskgård, Kevin Brady, Carsten Hofmann, Petra Rüger, Tilman Schlothauer, Ulrich Göpfert, Maximilian Hartl, Sylvia Rottach, Adrian Zwick, Shanon Seger, Rachel Neff, Jens Niewoehner, Niels Janssen